(Q38876677)

English

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel

scientific article published on 22 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

Gili Regev-Yochay

1

object named as

Gili Regev-Yochay

0 references

object named as

Yasmin Maor

7

0 references

10

object named as

Ron Dagan

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Jacob Strahilevitz

3

object named as

Jacob Strahilevitz

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

8

object named as

Bibiana Chazan

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

object named as

Galia Rahav

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Michal Katzir

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Talya Finn

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dan Miron

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yehudith Schindler

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

IAIPD group

11

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

22 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2449-2456

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Pneumococcal infection in adults: burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults With Underlying Comorbidities in Calgary, Alberta (2000-2013).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Pneumococcal Disease Prevention Among Adults: Strategies for the Use of Pneumococcal Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Identifiers

10.1016/J.VACCINE.2017.03.031

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38876677&oldid=1792956301"